Drug intelligence / Profile preview

fluorine F 18-BMS-986229

Development stage
Unknown
Lead developer
Bristol Myers Squibb
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptide-Drug Conjugates → Peptide Conjugates → Peptides
Administration
Intravenous
01

Overview

fluorine F 18-BMS-986229 is a radiopharmaceutical diagnostic agent consisting of a macrocyclic peptide (BMS-986229) labeled with the positron-emitting isotope fluorine‑18. It is designed as a high-affinity, selective ligand for programmed death-ligand 1 (PD-L1), enabling noninvasive imaging of PD-L1 expression in tumors using positron emission tomography (PET). The tracer demonstrates rapid clearance from non–PD-L1-expressing tissues and strong, specific binding to PD-L1, allowing for assessment of spatial heterogeneity in PD-L1 expression. It was developed using BMS‑986189 as the starting scaffold and optimized for radiolabeling and imaging performance. The primary clinical application is in oncology diagnostics, particularly to guide immunotherapy decisions by visualizing PD-L1 status in cancers such as gastroesophageal adenocarcinoma[1][2][4][6].

Other names
PD-L1 Macrocyclic Peptide PET TracerPD-L-1 Macrocyclic Peptide PET TracerPD-L 1 Macrocyclic Peptide PET Tracer
02

Targets

CD274 (Programmed cell death protein 1 ligand 1)

Beyond the preview

Go deeper on fluorine F 18-BMS-986229.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fluorine F 18-BMS-986229.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call